New Antiviral drug for COVID-19 treatment gets FDA Emergency Use Authorization !
- Marcel Filart

- May 2, 2020
- 1 min read
Updated: May 2, 2020
Remdesivir an experimental drug developed by Gilead as a treatment for Ebola virus disease. (used in trials in Liberia known as PREVAIL 4). Remdesivir is no longer being administered to patients with Ebola virus..
Remdesivir is FDA approved for SEVERE Covid-19 pneumonia in hospitalized patients. Dose: 200 mg IV on day 1 then 100mg IV once daily for up to 10 days.
“FDA’s emergency authorization of remdesivir, two days after the National Institutes of Health’s clinical trial showed promising results, is a significant step forward in battling COVID-19 and another example of the Trump Administration moving as quickly as possible to use science to save lives,” said HHS Secretary Alex Azar








This is promising news for continued COVID-19 treatment options. For the researchers behind this work, the next crucial step to maximize its impact will be to submit their medical research paper for publication in a reputable journal. This process allows for full peer review, shares their complete methodology and data with the global scientific community, and enables other clinicians to properly evaluate and build upon their findings.
The FDA’s emergency use authorization of the new COVID-19 treatment represents a major step forward in managing severe cases, offering hope for patients worldwide. Similarly, access to quality guidance in fields like Marketing Class Help helps individuals stay informed and make better decisions in fast-changing environments. Both highlight the importance of timely support, whether in healthcare or education, to empower people and improve outcomes in critical situations.
Wow! This is very good news the new Antiviral drug for covid-19 treatment gets FDA emergency ese authorization. thanks for sharing this information in your blog post please keep up your great work. If you need ARITHMETIC ASSIGNMENT HELP ONLINE so contact him because I am a user of this service and they are always help me when I need assignment help and that's why I really like this service.